Renovaro Inc.

NASDAQ:RENB

0.27

-0.03 (-9.15%)

7:54:47 PM EDT: $0.27 0.00 (-1.63%)

Renovaro Inc. Stock, NASDAQ:RENB

2080 Century Park East, Suite 906, Los Angeles, California 90067

United States of America

Phone: +1.305.918.1980

Number of Employees: 25

http://renovarobio.com

Description

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.